Founder and CEO of Antengene, Dr. Jay Mei, talks innovation in biotech, passion and learning from our mistakes

Pharmaceuticals
Founders
Leaders and senior executives
Private companies
Aasmah talks to Dr Jay Mei about how science is changing the world, why he is passionate about pharmaceuticals and what he has learnt from his experiences. To hear more stories of success, click here.
Aasmah Mir is an award winning broadcaster and journalist. She currently co-hosts the Breakfast Show on Times Radio and writes a regular column for The Times.
Dr. Mei has nearly 30 years of experience in clinical research and development of oncology therapeutics globally. He has published over 70 publications and is the co-inventor of multiple patents.
In the 1990s, Dr. Mei dedicated himself to extensive cancer research at the National Cancer Institute in the United States. In 2001, Dr. Mei joined as a Principal Scientist in the oncology team in the drug discovery division and Associate Director at Johnson & Johnson Pharmaceutical Research & Development, L.L.C.. From 2006, Dr. Mei worked as a Senior Director at Novartis Oncology, part of the Innovative Medicines division of Novartis AG. From 2008 to 2017, he served as an Executive Director of the clinical development department at Celgene (now part of Bristol-Myers Squibb). At Celgene, Dr. Mei was one of the leading members in the clinical development of multiple blockbuster drugs that represent the most significant part of Celgene’s portfolio today, including REVLIMID®, which is among the best-selling oncology therapies worldwide, and was also involved in the clinical development of POMALYST®, also one of the best-selling oncology drugs worldwide, and IDHIFA®, a first-in-class drug for the treatment of acute myeloid leukemia.
Dr. Mei has been a member of the American Society of Hematology since 2006 and was involved in the management of Antengene since April 2017. Dr. Mei also currently holds adjunct professorship at the Baruch S. Blumberg Institute.
Dr. Mei received his Doctor of Medicine (M.D.) degree from Hunan Medical University (now Xiangya School of Medicine of Central South University) in China and obtained his Doctor of Philosophy (Ph.D.) degree in pharmacology and toxicology from the University of Maryland in U.S.A.
What does it take to be successful and how do we navigate key moments in our lives? We explore stories of success with the FT.
We look beyond the pandemic, lockdowns and government funding, to what the future may hold and the opportunities for innovation
Read moreWe examine the challenges and issues facing clients in the Asia Pacific region, both personally and professionally
Read moreHow we can help entrepreneurs, investors and technology companies operating in a range of sectors including biotech, med-tech, food tech and health-tech (including digital health)
Read moreWe help successful people maximise opportunities, navigate complex legal situations and protect them from risks along the way. If you need our support, we’d be delighted to have a chat.
Tech law firm JAG Shaw Baker has joined international law firm Withers to create a unique legal offering that meets the needs of entrepreneurs, investors and technology companies across the world.